Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

Hemolytic uremic syndrome in a 65-Year-old male linked to a very unusual type of stx2e- and eae-harboring O51:H49 shiga toxin-producing Escherichia coli.

Fasel D, Mellmann A, Cernela N, Hächler H, Fruth A, Khanna N, Egli A, Beckmann C, Hirsch HH, Goldenberger D, Stephan R.

J Clin Microbiol. 2014 Apr;52(4):1301-3. doi: 10.1128/JCM.03459-13. Epub 2014 Feb 5.

2.

PCR-based detection and molecular characterization of shiga toxin-producing Escherichia coli strains in a routine microbiology laboratory over 16 years.

Haugum K, Brandal LT, Lindstedt BA, Wester AL, Bergh K, Afset JE.

J Clin Microbiol. 2014 Sep;52(9):3156-63. doi: 10.1128/JCM.00453-14. Epub 2014 Jun 11.

3.

Strong association between shiga toxin-producing Escherichia coli O157 and virulence genes stx2 and eae as possible explanation for predominance of serogroup O157 in patients with haemolytic uraemic syndrome.

Werber D, Fruth A, Buchholz U, Prager R, Kramer MH, Ammon A, Tschäpe H.

Eur J Clin Microbiol Infect Dis. 2003 Dec;22(12):726-30. Epub 2003 Nov 12.

PMID:
14614596
4.

Hemolytic uremic syndrome associated with Escherichia coli O8:H19 and Shiga toxin 2f gene.

Friesema IH, Keijzer-Veen MG, Koppejan M, Schipper HS, van Griethuysen AJ, Heck ME, van Pelt W.

Emerg Infect Dis. 2015 Jan;21(1):168-9. doi: 10.3201/eid2101.140515. No abstract available.

5.

Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms.

Friedrich AW, Bielaszewska M, Zhang WL, Pulz M, Kuczius T, Ammon A, Karch H.

J Infect Dis. 2002 Jan 1;185(1):74-84. Epub 2001 Dec 14.

PMID:
11756984
6.

Neonatal hemolytic uremic syndrome after mother-to-child transmission of a low-pathogenic stx2b harboring shiga toxin-producing Escherichia coli.

Stritt A, Tschumi S, Kottanattu L, Bucher BS, Steinmann M, von Steiger N, Stephan R, Hächler H, Simonetti GD.

Clin Infect Dis. 2013 Jan;56(1):114-6. doi: 10.1093/cid/cis851. Epub 2012 Oct 5.

7.

Defining pathogenic verocytotoxin-producing Escherichia coli (VTEC) from cases of human infection in the European Union, 2007-2010.

Messens W, Bolton D, Frankel G, Liebana E, McLAUCHLIN J, Morabito S, Oswald E, Threlfall EJ.

Epidemiol Infect. 2015 Jun;143(8):1652-61. doi: 10.1017/S095026881400137X.

PMID:
25921781
8.

Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany.

Frank C, Werber D, Cramer JP, Askar M, Faber M, an der Heiden M, Bernard H, Fruth A, Prager R, Spode A, Wadl M, Zoufaly A, Jordan S, Kemper MJ, Follin P, Müller L, King LA, Rosner B, Buchholz U, Stark K, Krause G; HUS Investigation Team.

N Engl J Med. 2011 Nov 10;365(19):1771-80. doi: 10.1056/NEJMoa1106483. Epub 2011 Jun 22.

9.

Emergence of Escherichia coli encoding Shiga toxin 2f in human Shiga toxin-producing E. coli (STEC) infections in the Netherlands, January 2008 to December 2011.

Friesema I, van der Zwaluw K, Schuurman T, Kooistra-Smid M, Franz E, van Duynhoven Y, van Pelt W.

Euro Surveill. 2014 May 1;19(17):26-32.

10.

The Shiga toxin genotype rather than the amount of Shiga toxin or the cytotoxicity of Shiga toxin in vitro correlates with the appearance of the hemolytic uremic syndrome.

Orth D, Grif K, Khan AB, Naim A, Dierich MP, Würzner R.

Diagn Microbiol Infect Dis. 2007 Nov;59(3):235-42. Epub 2007 Oct 10.

PMID:
17931818
11.

Verocytotoxin-producing Escherichia coli O128ab:H2 bacteremia in a 27-year-old male with hemolytic-uremic syndrome.

Buvens G, De Rauw K, Roisin S, Vanfraechem G, Denis O, Jacobs F, Scheutz F, Piérard D.

J Clin Microbiol. 2013 May;51(5):1633-5. doi: 10.1128/JCM.03025-12. Epub 2013 Mar 6.

12.

The epidemiology, microbiology and clinical impact of Shiga toxin-producing Escherichia coli in England, 2009-2012.

Byrne L, Jenkins C, Launders N, Elson R, Adak GK.

Epidemiol Infect. 2015 Dec;143(16):3475-87. doi: 10.1017/S0950268815000746. Epub 2015 Apr 29.

PMID:
25920912
13.

Shiga toxin-mediated hemolytic uremic syndrome: time to change the diagnostic paradigm?

Bielaszewska M, Köck R, Friedrich AW, von Eiff C, Zimmerhackl LB, Karch H, Mellmann A.

PLoS One. 2007 Oct 10;2(10):e1024.

14.

Hemolytic uremic syndrome following infection with O111 Shiga toxin-producing Escherichia coli revealed through molecular diagnostics.

Operario DJ, Moonah S, Houpt E.

J Clin Microbiol. 2014 Mar;52(3):1003-5. doi: 10.1128/JCM.02855-13. Epub 2013 Dec 26.

15.

An epidemiologic surveillance of Shiga-like toxin-producing Escherichia coli infection in Argentinean children: risk factors and serum Shiga-like toxin 2 values.

López EL, Contrini MM, Glatstein E, Ayala SG, Santoro R, Ezcurra G, Teplitz E, Matsumoto Y, Sato H, Sakai K, Katsuura Y, Hoshide S, Morita T, Harning R, Brookman S.

Pediatr Infect Dis J. 2012 Jan;31(1):20-4. doi: 10.1097/INF.0b013e31822ea6cf.

PMID:
21829137
16.
17.

Virulence factors for hemolytic uremic syndrome, Denmark.

Ethelberg S, Olsen KE, Scheutz F, Jensen C, Schiellerup P, Enberg J, Petersen AM, Olesen B, Gerner-Smidt P, Mølbak K.

Emerg Infect Dis. 2004 May;10(5):842-7.

18.

A new health threat in Europe: Shiga toxin-producing Escherichia coli O104:H4 infections.

Wu CJ, Hsueh PR, Ko WC.

J Microbiol Immunol Infect. 2011 Oct;44(5):390-3. doi: 10.1016/j.jmii.2011.07.001. Epub 2011 Sep 8. Review.

19.

[Detection, isolation and characterization of Shiga toxin-producing Escherichia coli (STEC) in fresh ground beef from butcher shops in Concepción, Tucumán Province].

Jure MA, Condorí S, Leotta GA, Chinen I, Miliwebsky E, Allori C, Aulet O, de Castillo MC.

Rev Argent Microbiol. 2010 Oct-Dec;42(4):284-7. doi: 10.1590/S0325-75412010000400009. Spanish.

20.

Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study.

Bielaszewska M, Mellmann A, Zhang W, Köck R, Fruth A, Bauwens A, Peters G, Karch H.

Lancet Infect Dis. 2011 Sep;11(9):671-6. doi: 10.1016/S1473-3099(11)70165-7. Epub 2011 Jun 22.

PMID:
21703928

Supplemental Content

Support Center